Patient Access Scheme Assessment Group / GlaxoSmithKline / Oncology Group / European Organization of Research / /
Country
United Kingdom / Scotland / /
Currency
GBP / /
Event
FDA Phase / /
IndustryTerm
anticancer medicinal products / treatment of melanoma / treatment of unresectable or metastatic melanoma / above product / chemical instability / Treatment of Cancer / therapy of metastatic disease / pharmaceutical company funding / treatment algorithm / food / /
European Organization of Research and Treatment of Cancer / American Joint Committee on Cancer / European Association of Dermato-Oncology / European Society for Medical Oncology / NHS / British Association of Dermatology / /